Cytosorbents (CTSO) Common Equity (2010 - 2026)
Cytosorbents' Common Equity was -$751,000 in Q2 2026, compared with $11.59 million a year earlier.
Powered by 
Analysis
Cytosorbents (CTSO) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Cytosorbents came in at $5.9 million, down 46.9% from FY2024.
- Common Equity has now declined for five consecutive years, with a five-year compound annual growth rate of -40.5% (FY2020 to FY2025).
- In earlier years, Common Equity was $11.11 million in FY2024 (-52.7%), $23.48 million in FY2023 (-33.6%), $35.37 million in FY2022 (-43.5%) and $62.58 million in FY2021 (-21.0%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q1 2017.
- Over the past five years, the year-over-year decline in Common Equity ranged from 12.0% (Q3 2021) to 84.9% (Q1 2026).
- Per Business Quant data, CTSO's Common Equity in the three quarters before Q2 2026 was $2.19 million (Q1 2026), $5.9 million (Q4 2025) and $9.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Cytosorbents | 12.57 Mn | -10.44 Mn | 7.05 Mn | -751,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -751,000.00 |
| Mar 31, 2026 | 2.19 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 9.02 Mn |
| Jun 30, 2025 | 11.59 Mn |
| Mar 31, 2025 | 14.54 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 13.38 Mn |
| Jun 30, 2024 | 17.43 Mn |
| Mar 31, 2024 | 19.63 Mn |
| Dec 31, 2023 | 23.48 Mn |
| Sep 30, 2023 | 18.81 Mn |
| Jun 30, 2023 | 24.46 Mn |
| Mar 31, 2023 | 29.94 Mn |
| Dec 31, 2022 | 35.37 Mn |
| Sep 30, 2022 | 39.14 Mn |
| Jun 30, 2022 | 47.56 Mn |
| Mar 31, 2022 | 55.43 Mn |
| Dec 31, 2021 | 62.58 Mn |
| Sep 30, 2021 | 70.61 Mn |
API Access
Cytosorbents Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CTSO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CTSO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CTSO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();